• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过去 5 年,乙型流感病毒在蒙古流行。

Influenza B viruses circulated during last 5 years in Mongolia.

机构信息

National Influenza Center, National Center for Communicable Diseases, Ministry of Health, Ulaanbaatar, Mongolia.

School of Bio-Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.

出版信息

PLoS One. 2018 Nov 15;13(11):e0206987. doi: 10.1371/journal.pone.0206987. eCollection 2018.

DOI:10.1371/journal.pone.0206987
PMID:30439983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6237300/
Abstract

Influenza B virus-caused illness has recently been considered as an urgent public health problem due to substantial morbidity, mortality and life-threatening medical complications. In this study, we have reported the main characteristics of influenza B virus in Mongolia, including prevalence, lineages, suitability with vaccine strains and drug susceptibility against the virus. 15768 specimens were tested by qPCR for detecting influenza viruses. From positive specimens for influenza B virus, the clinical isolates were isolated using MDCK cells. Sequencing analysis, hemagglutination inhibition assay and Neuraminidase inhibitor (NAI) drug susceptibility testing were performed for the clinical isolates. Influenza B virus was around in 3.46% of the samples in Mongolia, and B/Victoria clade-1A and B/Yamagata clade-3 lineages were predominant. Importantly, it was confirmed that the lineages corresponded to the vaccine strains. Moreover, drug susceptibility tests revealed that some Mongolian clinical isolates showed reduced susceptibility to antiviral agents. Interestingly, G104R was identified as a novel mutation, which might have a significant role in drug resistance of the virus. These results describe the characteristics of influenza B viruses that have caused respiratory illness in the population of Mongolia between 2013 and 2017.

摘要

乙型流感病毒引起的疾病由于发病率高、死亡率高以及危及生命的医疗并发症而被认为是当前一个紧迫的公共卫生问题。在本研究中,我们报告了蒙古乙型流感病毒的主要特征,包括流行率、谱系、与疫苗株的匹配性以及对病毒的药物敏感性。使用 qPCR 对 15768 个标本进行流感病毒检测。从乙型流感病毒阳性标本中,使用 MDCK 细胞分离临床分离株。对临床分离株进行测序分析、血凝抑制试验和神经氨酸酶抑制剂(NAI)药物敏感性测试。乙型流感病毒在蒙古的样本中占 3.46%,B/Victoria 谱系 1A 和 B/Yamagata 谱系 3 是主要的谱系。重要的是,证实了这些谱系与疫苗株相对应。此外,药物敏感性测试显示,一些蒙古临床分离株对抗病毒药物的敏感性降低。有趣的是,鉴定出 G104R 是一种新的突变,它可能在病毒的耐药性中起重要作用。这些结果描述了 2013 年至 2017 年期间引起蒙古人群呼吸道疾病的乙型流感病毒的特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a19/6237300/563b81e1a7c4/pone.0206987.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a19/6237300/4de595aa9210/pone.0206987.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a19/6237300/68614955bc90/pone.0206987.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a19/6237300/f6a29667e2b1/pone.0206987.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a19/6237300/c8e424f215b4/pone.0206987.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a19/6237300/563b81e1a7c4/pone.0206987.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a19/6237300/4de595aa9210/pone.0206987.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a19/6237300/68614955bc90/pone.0206987.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a19/6237300/f6a29667e2b1/pone.0206987.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a19/6237300/c8e424f215b4/pone.0206987.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a19/6237300/563b81e1a7c4/pone.0206987.g005.jpg

相似文献

1
Influenza B viruses circulated during last 5 years in Mongolia.过去 5 年,乙型流感病毒在蒙古流行。
PLoS One. 2018 Nov 15;13(11):e0206987. doi: 10.1371/journal.pone.0206987. eCollection 2018.
2
Mutations at the monomer-monomer interface away from the active site of influenza B virus neuraminidase reduces susceptibility to neuraminidase inhibitor drugs.流感 B 病毒神经氨酸酶单体-单体界面远离活性部位的突变降低了对神经氨酸酶抑制剂药物的敏感性。
J Infect Chemother. 2013 Oct;19(5):891-5. doi: 10.1007/s10156-013-0589-6. Epub 2013 Mar 26.
3
Neuraminidase inhibitor susceptibility and evolutionary analysis of human influenza B isolates from three Asian countries during 2012-2015.2012-2015 年三个亚洲国家的人乙型流感分离株的神经氨酸酶抑制剂敏感性和进化分析。
Infect Genet Evol. 2018 Aug;62:27-33. doi: 10.1016/j.meegid.2018.04.016. Epub 2018 Apr 14.
4
A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.单个远离流感 B 病毒神经氨酸酶活性部位的 E105K 突变有助于降低对多种神经氨酸酶抑制剂药物的敏感性。
Biochem Biophys Res Commun. 2012 Dec 7;429(1-2):51-6. doi: 10.1016/j.bbrc.2012.10.095. Epub 2012 Nov 3.
5
Influenza B viruses from different genetic backgrounds are variably impaired by neuraminidase inhibitor resistance-associated substitutions.不同遗传背景的乙型流感病毒对神经氨酸酶抑制剂耐药相关突变的敏感性存在差异。
Antiviral Res. 2020 Jan;173:104669. doi: 10.1016/j.antiviral.2019.104669. Epub 2019 Nov 29.
6
Outcomes and Susceptibility to Neuraminidase Inhibitors in Individuals Infected With Different Influenza B Lineages: The Influenza Resistance Information Study.不同流感 B 谱系感染个体的结局和对神经氨酸酶抑制剂的敏感性:流感耐药性信息研究。
J Infect Dis. 2016 Jan 15;213(2):183-90. doi: 10.1093/infdis/jiv375. Epub 2015 Jul 9.
7
Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.2009-2010 年和 2010-2011 年流感季节日本大流行和季节性流感病毒的神经氨酸酶抑制剂敏感性特征。
Antiviral Res. 2013 Sep;99(3):261-9. doi: 10.1016/j.antiviral.2013.06.003. Epub 2013 Jun 17.
8
[Susceptibility of Influenza B Viruses to Neuraminidase Inhibitors Isolated during 2013-2014 Influenza Season in Mainland China].[2013 - 2014年中国大陆流感季节分离出的乙型流感病毒对神经氨酸酶抑制剂的敏感性]
Bing Du Xue Bao. 2015 Mar;31(2):152-6.
9
Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir.2010 年和 2011 年中国乙型流感病毒的神经氨酸酶抑制剂敏感性检测发现对奥司他韦和扎那米韦敏感性降低的病毒。
Antiviral Res. 2013 Mar;97(3):240-4. doi: 10.1016/j.antiviral.2012.12.013. Epub 2012 Dec 23.
10
Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.扎那米韦耐药的流感病毒在 MDCK 细胞培养过程中可出现 Q136K 或 Q136R 神经氨酸酶残基突变,这给抗病毒药物敏感性监测带来了挑战。
Euro Surveill. 2015;20(45). doi: 10.2807/1560-7917.ES.2015.20.45.30060.

引用本文的文献

1
Fast-Flu: RT-RPA-CRISPR/Cas12a assisted one-step platform for rapid influenza B virus detection.快速流感:RT-RPA-CRISPR/Cas12a辅助的一步式快速检测乙型流感病毒平台
Microbiol Spectr. 2025 Jun 3;13(6):e0036525. doi: 10.1128/spectrum.00365-25. Epub 2025 Apr 25.
2
A potential Chinese medicine monomer against influenza A virus and influenza B virus: isoquercitrin.一种潜在的抗甲型流感病毒和乙型流感病毒的中药单体:异槲皮苷。
Chin Med. 2023 Nov 2;18(1):144. doi: 10.1186/s13020-023-00843-4.
3
Handwashing Practice among Elementary Schoolchildren in Urban Setting, Mongolia: A School-Based Cross-Sectional Survey.

本文引用的文献

1
How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.世卫组织欧洲区域各国距离为主要风险群体接种 75%流感疫苗的目标还有多远?2008/2009 至 2014/2015 年国家季节性流感疫苗接种规划调查结果。
Vaccine. 2018 Jan 25;36(4):442-452. doi: 10.1016/j.vaccine.2017.12.019. Epub 2017 Dec 26.
2
Vaccine-mismatched influenza B/Yamagata lineage viruses in Cuba, 2012-2013 season.2012-2013 年古巴流行的与疫苗不匹配的乙型流感/Yamagata 系病毒。
Infect Genet Evol. 2018 Mar;58:110-114. doi: 10.1016/j.meegid.2017.12.004. Epub 2017 Dec 8.
3
蒙古国城市环境中小学生洗手习惯:基于学校的横断面调查。
J Environ Public Health. 2022 Sep 16;2022:3103241. doi: 10.1155/2022/3103241. eCollection 2022.
4
Incident changes in the prevalence of influenza virus during COVID-19 pandemic in Hangzhou, China.中国杭州新冠疫情期间流感病毒流行率的突发变化。
Clin Respir J. 2022 Sep;16(9):623-625. doi: 10.1111/crj.13531. Epub 2022 Aug 4.
5
Epidemiology and Genetic Variability of Circulating Influenza B Viruses in Uruguay, 2012-2019.2012 - 2019年乌拉圭流行的乙型流感病毒的流行病学和基因变异性
Microorganisms. 2020 Apr 19;8(4):591. doi: 10.3390/microorganisms8040591.
Age and immunity: What is "immunosenescence"?
年龄与免疫:什么是“免疫衰老”?
Exp Gerontol. 2018 May;105:4-9. doi: 10.1016/j.exger.2017.10.024. Epub 2017 Oct 27.
4
Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals.基于荧光的神经氨酸酶抑制试验,用于评估流感病毒对神经氨酸酶抑制剂类抗病毒药物的敏感性。
J Vis Exp. 2017 Apr 15(122):55570. doi: 10.3791/55570.
5
Antigenic and genetic characterization of influenza viruses circulating in Bulgaria during the 2015/2016 season.2015/2016年流行于保加利亚的流感病毒的抗原性和基因特征
Infect Genet Evol. 2017 Apr;49:241-250. doi: 10.1016/j.meegid.2017.01.027. Epub 2017 Jan 27.
6
Influenza B burden during seasonal influenza epidemics in France.法国季节性流感流行期间 B 型流感负担。
Med Mal Infect. 2017 Feb;47(1):11-17. doi: 10.1016/j.medmal.2016.11.006. Epub 2017 Jan 3.
7
Prediction of influenza B vaccine effectiveness from sequence data.根据序列数据预测乙型流感疫苗的有效性。
Vaccine. 2016 Aug 31;34(38):4610-4617. doi: 10.1016/j.vaccine.2016.07.015. Epub 2016 Jul 26.
8
Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: A systematic review and meta-analysis of randomised controlled trials.成人四价流感病毒裂解疫苗的免疫原性和安全性:随机对照试验的系统评价和荟萃分析
Vaccine. 2016 Jul 29;34(35):4092-4102. doi: 10.1016/j.vaccine.2016.06.064. Epub 2016 Jul 2.
9
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.2014 - 2015年全球人类流感病毒对神经氨酸酶抑制剂敏感性的最新情况
Antiviral Res. 2016 Aug;132:178-85. doi: 10.1016/j.antiviral.2016.06.001. Epub 2016 Jun 3.
10
Influenza B vaccine lineage selection--an optimized trivalent vaccine.乙型流感疫苗谱系选择——一种优化的三价疫苗。
Vaccine. 2016 Mar 18;34(13):1617-1622. doi: 10.1016/j.vaccine.2016.01.042. Epub 2016 Feb 16.